Clinical Trials Browser

OTHER × First-line Treatment × lenvatinib × Clear all

NCT05221775 2022-02-03

Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients

Phase 1 Unknown

Gastrointestinal

First-line Treatment